Sanara MedTech Inc.
FORT WORTH, TX / ACCESSWIRE / August 2, 2021 / Sanara MedTech Inc.
Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ:SMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today details for the release of its results for the second quarter ended June 30, 2021.
Sanara plans to issue its earnings release after the market closes on Monday, August 16, 2021, and will host a conference call on Tuesday, August 17, 2021, at 9:00 a.m. Eastern Time. The toll-free number to call for this teleconference is 844-407-9500 (international callers: 862-298-0850). A telephonic replay of the conference call will be available through Tuesday, August 31, 2021, by dialing 877-481-4010 (international callers: 919-882-2331) and entering the replay passcode: 42396.
A live webcast of Sanara's conference call will be available under the Investor Relations section of the Company's website, www.SanaraMedTech.com. A one-year online replay will be available after the conclusion of the live broadcast.
About Sanara MedTech Inc.
With a focus on improving patient outcomes through evidence-based healing solutions, Sanara MedTech Inc. markets, distributes, and develops wound and skincare products for use by physicians and clinicians in hospitals, clinics, and all post-acute care settings and is seeking to offer wound care and dermatology virtual consultation services via telemedicine. Sanara's products are primarily sold in the North American advanced wound care and surgical tissue repair markets. Sanara MedTech markets and distributes CellerateRX® Surgical Activated Collagen® to the surgical markets as well as the following products to the wound care market: BIAKŌS™ Antimicrobial Skin and Wound Cleanser, BIAKŌS™ Antimicrobial Wound Gel, BIAKŌS™ Antimicrobial Skin and Wound Irrigation Solution and HYCOL™ Hydrolyzed Collagen. Through the Rochal Industries, LLC ("Rochal") asset acquisition, Sanara's pipeline contains potentially transformative product candidates for mitigation of opportunistic pathogens and biofilm, wound re-epithelialization and closure, necrotic tissue debridement, and cell compatible substrates. The Company believes it has acquired the ability to drive its pipeline from concept to preclinical and clinical development while meeting quality and regulatory requirements. Sanara is constantly seeking long-term strategic partnerships with a focus on products that improve outcomes at a lower overall cost. In addition, Sanara is actively seeking to expand within its six focus areas of wound and skincare for the acute, post-acute, and surgical markets. The focus areas are debridement, biofilm removal, hydrolyzed collagen, advanced biologics, negative pressure wound therapy adjunct products, and the oxygen delivery system segment of the healthcare industry. For more information, visit SanaraMedTech.com.
Information about Forward-Looking Statements
The statements in this press release that do not constitute historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. These statements may be identified by terms such as "anticipate," "believes," "contemplates," "continue" "could," "estimates," "expect," "intend," "may," "plan," "potential" "predicts," "preliminary," "project," "seek," "should," "target," "will," or "would," or the negatives of these terms, variations of these terms or other similar expressions. These forward-looking statements include statements regarding the development of new products and expansion of the Company's business in telehealth and wound care. These items involve risks, contingencies and uncertainties such as Sanara's ability to successfully integrate the acquired business and operations of Rochal, including Sanara's ability to retain key employees following the acquisition, unexpected costs or expenses that may result from the acquisition, uncertainties associated with the development and process for obtaining regulatory approval for new products, the extent of product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the Company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements.
All forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events, except as required by applicable securities laws.
Investor Contact:
Callon Nichols, Director of Investor Relations
713-826-0524
CNichols@sanaramedtech.com
SOURCE: Sanara MedTech Inc.
View source version on accesswire.com:
https://www.accesswire.com/657935/Sanara-MedTech-Inc-Announces-Second-Quarter-2021-Earnings-Release-and-Conference-Call-Dates
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
FINOS Launches Fluxnova with Fidelity Investments, NatWest Group, Deutsche Bank and Capital One - An Open Source Orchestration Platform to Scale Process Automation21.10.2025 18:00:00 CEST | Press release
Announced at the Open Source in Finance Forum (OSFF), Fluxnova empowers financial institutions to modernize their infrastructure, reduce vendor dependency, and build long-term industry resilience. NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / The Fintech Open Source Foundation (FINOS), the foundation of open innovation in financial services, today announced the launch of Fluxnova, an open orchestration platform developed in partnership with Fidelity Investments, NatWest Group, Deutsche Bank, and Capital One. Fluxnova delivers audit-ready workflows at scale, helping institutions visualize and automate their processes. By doing so, companies are better positioned to modernize operations and maintain strong governance across their processes. Fluxnova offers developers a toolkit for designing and deploying Business Process Model and Notation (BPMN) and Decision Model and Notation (DMN) models with a high-performance engine to execute and trace workflows. Business teams gain tran
Foundry Welcomes Gregory Anderson as Global Chief Revenue Officer21.10.2025 15:00:00 CEST | Press release
Global Sales Leader to Drive Unified Strategy and Accelerate Customer-Centric Growth NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Foundry, the leading global tech media, data, and marketing services company, is thrilled to announce the appointment of Gregory Anderson as Global Chief Revenue Officer (CRO). With two decades of proven success driving sales performance across technology and media sectors, Anderson joins Foundry with a clear focus on enhancing the buyer journey and accelerating strategic growth globally. Anderson joins Foundry from Informa TechTarget, where he most recently served as Chief Sales Officer at Omdia. During his tenure, he held several other key leadership roles, including positions leading sales and the integration of major acquisitions such as BrightTALK and Enterprise Strategy Group (ESG). He also spent eight years as VP of Sales for APAC at Informa TechTarget, where he helped expand regional operations. "We are thrilled to welcome Greg to the Fou
Air T Enters into Agreement with Regional Express Holdings Limited21.10.2025 12:00:00 CEST | Press release
MINNEAPOLIS, MINNESOTA / ACCESS Newswire / October 21, 2025 / Air T, Inc. (NASDAQ:AIRT) has entered into a Sale and Implementation Deed (SID) with the Administrators of Regional Express Holdings Limited (Administrators Appointed) and certain of its subsidiaries (Rex), which operates the leading regional airline in Australia. Air T expects to close the acquisition of Rex by year-end if creditor and other approvals are obtained. Air T has been working closely with the Administrators and the Australian Government, Rex's secured lender, to develop a solution that best serves the interests of all stakeholders. To support the implementation of the acquisition, Air T and the Commonwealth of Australia have entered into an agreement pursuant to which Rex's financing arrangements will be restructured in connection with the acquisition. The proposed acquisition contemplates a continuation and growth of Rex's regional airline business and continuing employment for its workforce. Rex plays an essen
Ubiquity Strengthens European Leadership with Appointment of Megan Porter as EVP, UK & Europe21.10.2025 09:00:00 CEST | Press release
Appointment underscores Ubiquity's continued investment in Europe, expanding onshore and offshore CX delivery to support global clients with scalable, multilingual solutions. LONDON, GB / ACCESS Newswire / October 21, 2025 / Ubiquity, a global provider of customer experience (CX) and business process outsourcing (BPO) solutions, today announced the appointment of Megan Porter as Executive Vice President, UK & Europe. In her new role, Porter will lead regional growth efforts, build local partnerships, and represent Ubiquity's expanding presence across the UK and wider European markets. The appointment comes as Ubiquity continues to accelerate its investment in the region with the opening of its Sheffield, UK delivery centre, expanding capacity to support onshore programmes for fintech, healthcare, insurance, and e-commerce clients. This expansion complements Ubiquity's nearshore and offshore capabilities across Accra, Ghana, and Eastern Europe, providing flexible, multilingual support t
Clean Air Metals Drilling Confirms Down-Plunge Extension of the Escape Deposit20.10.2025 13:00:00 CEST | Press release
THUNDER BAY, ON / ACCESS Newswire / October 20, 2025 / Clean Air Metals Inc. ("Clean Air Metals" or the "Company") (TSX.V:AIR)(FRA:CKU)(OTCQB:CLRMF) is pleased to announce that its 2025 summer drilling program at the Company's 100%-owned Thunder Bay North Critical Minerals Project ("TBN") has confirmed the continuation of the Escape Deposit into a previously untested 2.5 km long magnetic anomaly that connects to the known mineral resources. The single hole completed during this program intersected high-tenor sulphide mineralization having comparable thickness and metal grades to the existing Escape Deposit resource. Given its significant size, the Escape down-plunge target represents the highest potential resource addition opportunity for the TBN project. Assay highlights from hole EL25-001: 53 m of 0.52 g/t Pt, 0.69 g/t Pd, 0.26% Cu and 0.17% Ni(from 404 m downhole, including 0.84 g/t Pt, 1.12 g/t Pd, 0.41% Cu and 021% Ni over 22 m from 411 m, and 1.08 g/t Pt, 1.41 g/t Pd, 0.52% Cu an
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom